ReviewFrontiers in immunology2025
NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease.
María Virginia Pinzón-Fernández et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it